Vor Bio appoints Sandy Mahatme as CFO

3 hours ago 1

Vor Bio (NASDAQ:VOR) announced on Thursday the appointment of Sandy Mahatme as Chief Financial Officer and Chief Business Officer, effective July 9, 2025.
Mahatme joins Vor Bio with more than 30 years of executive leadership experience in the biopharmaceutical industry. He

Recommended For You